These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18183582)

  • 1. Design, structural, and immuno-analytical properties of antigenic bioconjugates comprising a beta-amyloid-plaque specific epitope.
    Manea M; Przybylski M; Hudecz F; Mezö G
    Biopolymers; 2008; 90(2):94-104. PubMed ID: 18183582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, solution conformation, and antibody recognition of oligotuftsin-based conjugates containing a beta-amyloid(4-10) plaque-specific epitope.
    Manea M; Hudecz F; Przybylski M; Mezõ G
    Bioconjug Chem; 2005; 16(4):921-8. PubMed ID: 16029033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypeptide conjugates comprising a beta-amyloid plaque-specific epitope as new vaccine structures against Alzheimer's disease.
    Manea M; Mezö G; Hudecz F; Przybylski M
    Biopolymers; 2004; 76(6):503-11. PubMed ID: 15499564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody recognition and conformational flexibility of a plaque-specific beta-amyloid epitope modulated by non-native peptide flanking regions.
    Manea M; Kalászi A; Mezo G; Horváti K; Bodor A; Horváth A; Farkas O; Perczel A; Przybylski M; Hudecz F
    J Med Chem; 2008 Mar; 51(5):1150-61. PubMed ID: 18284185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc binding agonist effect on the recognition of the beta-amyloid (4-10) epitope by anti-beta-amyloid antibodies.
    Zirah S; Stefanescu R; Manea M; Tian X; Cecal R; Kozin SA; Debey P; Rebuffat S; Przybylski M
    Biochem Biophys Res Commun; 2004 Aug; 321(2):324-8. PubMed ID: 15358179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and comparison of antibody recognition of conjugates containing herpes simplex virus type 1 glycoprotein D epitope VII.
    Mezö G; de Oliveira E; Krikorian D; Feijlbrief M; Jakab A; Tsikaris V; Sakarellos C; Welling-Wester S; Andreu D; Hudecz F
    Bioconjug Chem; 2003; 14(6):1260-9. PubMed ID: 14624643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.
    Bard F; Barbour R; Cannon C; Carretto R; Fox M; Games D; Guido T; Hoenow K; Hu K; Johnson-Wood K; Khan K; Kholodenko D; Lee C; Lee M; Motter R; Nguyen M; Reed A; Schenk D; Tang P; Vasquez N; Seubert P; Yednock T
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2023-8. PubMed ID: 12566568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential order of T and B cell epitopes affects immunogenicity but not antibody recognition of the B cell epitope.
    Denton G; Hudecz F; Kajtár J; Murray A; Tendler SJ; Price MR
    Pept Res; 1994; 7(5):258-64. PubMed ID: 7531518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody capture of soluble Abeta does not reduce cortical Abeta amyloidosis in the PDAPP mouse.
    Seubert P; Barbour R; Khan K; Motter R; Tang P; Kholodenko D; Kling K; Schenk D; Johnson-Wood K; Schroeter S; Gill D; Jacobsen JS; Pangalos M; Basi G; Games D
    Neurodegener Dis; 2008; 5(2):65-71. PubMed ID: 18182780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice.
    Muhs A; Hickman DT; Pihlgren M; Chuard N; Giriens V; Meerschman C; van der Auwera I; van Leuven F; Sugawara M; Weingertner MC; Bechinger B; Greferath R; Kolonko N; Nagel-Steger L; Riesner D; Brady RO; Pfeifer A; Nicolau C
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9810-5. PubMed ID: 17517595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and conformational properties of an N-linked glycosylated peptide epitope of human T-lymphotropic virus type 1 (HTLV-I).
    Conrad SF; Byeon IJ; DiGeorge AM; Lairmore MD; Tsai MD; Kaumaya PT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(2):83-92. PubMed ID: 9346859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structural characterization of bioactive peptide conjugates using thioether linkage approaches.
    Mezö G; Manea M; Jakab A; Kapuvári B; Bösze S; Schlosser G; Przybylski M; Hudecz F
    J Pept Sci; 2004 Dec; 10(12):701-13. PubMed ID: 15635622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards Alzheimer's beta-amyloid vaccination.
    Frenkel D; Solomon B
    Biologicals; 2001; 29(3-4):243-7. PubMed ID: 11851323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and therapeutic efficacy of phage-displayed beta-amyloid epitopes.
    Esposito M; Luccarini I; Cicatiello V; De Falco D; Fiorentini A; Barba P; Casamenti F; Prisco A
    Mol Immunol; 2008 Feb; 45(4):1056-62. PubMed ID: 17850871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of anti-beta-amyloid antibodies via phage display technology towards Alzheimer's disease vaccination.
    Solomon B
    Vaccine; 2005 Mar; 23(17-18):2327-30. PubMed ID: 15755621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic, antigenic, fibrillogenic and inflammatory properties of new simplified beta-amyloid peptides.
    Rossi M; Piovesan P; Ghirardi O; Mastroianni D; Bombardi V; Battistini L; Cencioni MT; Capobianco D; Borsini F; Colombo M; Verdoliva A
    Mol Immunol; 2009 Aug; 46(13):2524-32. PubMed ID: 19535144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immune responses to peptides derived from the beta-amyloid peptide C-terminal sequence.
    Miller DL; Potempska A; Mehta PD
    Amyloid; 2007 Mar; 14(1):39-50. PubMed ID: 17453624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fully synthetic immunogens. Part III. Synthesis of hinge-peptide/gastrin conjugates and their immunological properties.
    Wünsch E; Moroder L; Hübener G; Musiol HJ; Von Grünigen R; Göhring W; Scharf R; Schneider CH
    Int J Pept Protein Res; 1991 Feb; 37(2):90-102. PubMed ID: 1708369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of sequential oligopeptide carriers on the bioactive structure of conjugated epitopes: comparative study of the conformation of a Herpes simplex virus glycoprotein gD-1 epitope in the free and conjugated form, and protein "built-in" crystal structure.
    Krikorian D; Stavrakoudis A; Biris N; Sakarellos C; Andreu D; de Oliveira E; Mezö G; Majer Z; Hudecz F; Welling-Wester S; Cung MT; Tsikaris V
    Biopolymers; 2006; 84(4):383-99. PubMed ID: 16493659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.